CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF Determinants of exercise intolerance in heart failure with preserved ejection fraction: A systematic review and meta-analysis sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T Good response to tolvaptan shortens hospitalization in patients with congestive heart failure Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial Respiratory Syncytial Virus and Associations With Cardiovascular Disease in Adults Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol

Editorial2021 Jan 20;S0828-282X(21)00051-9.

JOURNAL:Can J Cardiol. Article Link

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"

JG Howlett. Keywords: angiotensin receptor/neprilysin inhibitor; HF

Full Text PDF